Zevra Therapeutics Inc. (ZVRA)
Healthcare
Biotechnology
9.50 $
-1.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Zevra Therapeutics Inc. (ZVRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -1.6 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15 | -20 | -30 | -33 | -54 | -24 | -1.9 | 10 | -19 | -34 | -70 | -1.6 | |
| 0.1 | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.9 | 1.0 | 6.4 | 4.1 | |
| 0.2 | 2.4 | 6.6 | 4.6 | 6.5 | 4.4 | 2.5 | 2.4 | 4.3 | 6.0 | 15 | 13 | |
| – | – | – | – | – | 3.8 | 7.9 | 19 | 22 | – | – | – | |
| 1.5 | 0.1 | 3.3 | -1.7 | -2.3 | -5.1 | 0.4 | -0.4 | -0.4 | 5.9 | -6.6 | -27 | |
| 0.0 | 0.1 | 0.6 | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.0 | 0.8 | |
| 0.0 | -19 | -47 | 27 | 33 | 3.2 | 0.0 | -16 | -37 | -17 | -22 | 18 | |
| – | – | – | – | – | – | – | 31 | 0.3 | – | – | – | |
| – | – | – | – | – | – | 0.0 | -2.8 | -4.7 | -3.4 | 0.0 | – | |
| – | – | – | – | – | -0.2 | 0.6 | -38 | 13 | 25 | 16 | 0.0 | |
| 23 | 61 | 61 | -0.2 | 28 | 4.9 | 2.7 | 113 | 8.4 | 28 | 82 | 12 | |
| 8.3 | 22 | -16 | -5.9 | 7.1 | -16 | 0.8 | 108 | -47 | -22 | -9.3 | 29 | |
| -15 | -20 | -30 | -33 | -54 | -24 | -2.0 | 10 | -19 | -34 | -70 | -2.4 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.